+919405117673
Sorafenib Tablets Supplier and Distributor in India to UK
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical supplier and distributor offering Sorafenib Tablets for international pharmaceutical supply from India to the United Kingdom. We support enquiries from pharmaceutical distributors, wholesalers, hospitals, healthcare organizations and authorized medicine procurement partners seeking reliable sourcing of Sorafenib from India.

Sorafenib Tablets from India

Sorafenib is a targeted anticancer medicine containing sorafenib, commonly supplied as sorafenib tosylate. In the UK, Sorafenib 200 mg film-coated tablets are listed in established medicines references.

Sorafenib is used under specialist medical supervision for specific cancers, including advanced hepatocellular carcinoma and differentiated thyroid cancer in accordance with applicable clinical guidance. UK NHS formularies identify Sorafenib 200 mg tablets as a specialist/restricted medicine for appropriate indications.

Sorafenib Tablets Supplier in India

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical sourcing and export support for Sorafenib Tablets from India to UK. Our services are intended for authorized buyers and professional pharmaceutical procurement requirements.

We can assist with:

Sorafenib Tablets sourcing from India
Bulk pharmaceutical enquiries
Distributor and wholesaler requirements
Hospital procurement enquiries
Export documentation support
Product and packaging information
Shipping coordination from India
Commercial quotations for eligible buyers
Sorafenib Tablets Distributor for UK

For UK procurement, pharmaceutical imports and distribution must follow applicable UK requirements. Depending on the product and import route, licensing and regulatory requirements may apply, including requirements involving UK wholesale distribution authorization and MHRA processes.

Cordium Pharmaceuticals Pvt Ltd works with buyers to provide relevant product and export documentation for their procurement and regulatory review.

Sorafenib 200 mg Tablets

Sorafenib 200 mg is an oral film-coated tablet formulation. UK product information confirms that each tablet contains sorafenib equivalent to 200 mg as sorafenib tosylate.

The appropriate dose and treatment schedule must be determined by the treating oncologist according to the patient's condition, treatment history and applicable prescribing information. Do not use Sorafenib without a valid prescription and professional medical supervision.

Storage and Packaging

Sorafenib tablets should be stored according to the approved product packaging and product information. A UK Sorafenib patient leaflet states that the medicine should not be stored above 30°C and should be kept out of the sight and reach of children.

Cordium can provide available packaging, batch, expiry and shipping information to authorized buyers before order confirmation.

Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical supplier and distributor
International pharmaceutical export support
Sorafenib sourcing for authorized buyers
Bulk and distributor enquiries accepted
Documentation and shipping coordination
Professional quotation support
Supply from India to international markets
Sorafenib Tablets Export from India to UK

If you are looking for a Sorafenib Tablets supplier in India for UK pharmaceutical procurement, Cordium Pharmaceuticals Pvt Ltd can assist with product availability, quotation, packaging details and export requirements.

For UK orders, customers should ensure that the proposed importation, distribution and use comply with applicable MHRA, UK licensing and prescription requirements. UK guidance specifies different requirements depending on whether a medicine is licensed, unlicensed, imported for special use, or supplied through other authorized routes.

Request a Sorafenib Tablets Quotation

Contact Cordium Pharmaceuticals Pvt Ltd for Sorafenib Tablets supply enquiries from India to the UK. Share your required strength, quantity, destination and buyer details to receive product availability and commercial information.

Sep 11th, 2026 5:57 PM

Keywords